LM-108 in Combination With PD-1 Based Treatment for Patients With Recurrent or Metastatic Triple - Negative Breast Cancer

Clinical trial NCT06387628 · RECRUITING

Trial details

NCT number: NCT06387628
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

TNBC - Triple-Negative Breast Cancer

Start date: 2024-07-10
Primary completion: 2026-04-01
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.